Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 3 | 2025 | 227 | 1.910 |
Why?
|
| Genital Neoplasms, Female | 3 | 2021 | 112 | 1.790 |
Why?
|
| Hysterectomy | 4 | 2024 | 167 | 1.420 |
Why?
|
| Analgesia, Epidural | 2 | 2020 | 42 | 1.260 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 797 | 1.150 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2025 | 59 | 0.870 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2022 | 61 | 0.730 |
Why?
|
| Oncologists | 1 | 2021 | 38 | 0.680 |
Why?
|
| Drug Costs | 1 | 2021 | 66 | 0.650 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 492 | 0.650 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 361 | 0.570 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 49 | 0.550 |
Why?
|
| Telemedicine | 1 | 2021 | 225 | 0.540 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 73 | 0.540 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 546 | 0.520 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2017 | 92 | 0.500 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1448 | 0.430 |
Why?
|
| Postoperative Complications | 3 | 2020 | 2562 | 0.430 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 446 | 0.400 |
Why?
|
| Fallopian Tubes | 2 | 2025 | 48 | 0.400 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 220 | 0.350 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 767 | 0.340 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 368 | 0.340 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2544 | 0.340 |
Why?
|
| Female | 12 | 2025 | 48702 | 0.300 |
Why?
|
| Neoplasm Staging | 2 | 2025 | 2017 | 0.270 |
Why?
|
| Retrospective Studies | 4 | 2025 | 10164 | 0.240 |
Why?
|
| Humans | 14 | 2025 | 93515 | 0.240 |
Why?
|
| Databases, Factual | 2 | 2020 | 1006 | 0.220 |
Why?
|
| Aged | 6 | 2025 | 20434 | 0.220 |
Why?
|
| Tertiary Care Centers | 1 | 2025 | 129 | 0.220 |
Why?
|
| Menstrual Cycle | 1 | 2025 | 59 | 0.210 |
Why?
|
| United States | 4 | 2024 | 7622 | 0.210 |
Why?
|
| Menopause | 1 | 2025 | 87 | 0.210 |
Why?
|
| Middle Aged | 7 | 2025 | 27573 | 0.210 |
Why?
|
| Geography | 2 | 2021 | 240 | 0.200 |
Why?
|
| Rural Health Services | 1 | 2021 | 17 | 0.170 |
Why?
|
| Ovary | 1 | 2022 | 254 | 0.170 |
Why?
|
| Quality of Health Care | 1 | 2024 | 382 | 0.170 |
Why?
|
| Decision Trees | 1 | 2021 | 64 | 0.170 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 7061 | 0.170 |
Why?
|
| Microsatellite Instability | 1 | 2021 | 64 | 0.170 |
Why?
|
| Markov Chains | 1 | 2021 | 135 | 0.170 |
Why?
|
| Phenylurea Compounds | 1 | 2021 | 97 | 0.170 |
Why?
|
| Quinolines | 1 | 2021 | 85 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2025 | 700 | 0.160 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 156 | 0.160 |
Why?
|
| Rural Population | 1 | 2021 | 170 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 481 | 0.160 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2020 | 37 | 0.160 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 277 | 0.160 |
Why?
|
| Registries | 1 | 2025 | 990 | 0.160 |
Why?
|
| Carboplatin | 1 | 2021 | 322 | 0.160 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 85 | 0.150 |
Why?
|
| Propensity Score | 1 | 2020 | 178 | 0.150 |
Why?
|
| Paclitaxel | 1 | 2021 | 479 | 0.150 |
Why?
|
| Anesthesia, General | 1 | 2020 | 128 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2020 | 175 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 486 | 0.140 |
Why?
|
| Pneumonia | 1 | 2020 | 193 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2018 | 96 | 0.140 |
Why?
|
| Food Supply | 1 | 2018 | 31 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 237 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 257 | 0.130 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 226 | 0.130 |
Why?
|
| Adult | 5 | 2025 | 27918 | 0.130 |
Why?
|
| Incidence | 1 | 2021 | 1701 | 0.130 |
Why?
|
| Operative Time | 1 | 2017 | 167 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2020 | 485 | 0.120 |
Why?
|
| Length of Stay | 1 | 2020 | 828 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2022 | 4560 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 412 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 1001 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 876 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 867 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1713 | 0.100 |
Why?
|
| Age Factors | 1 | 2018 | 1906 | 0.100 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2013 | 78 | 0.090 |
Why?
|
| Quality of Life | 1 | 2021 | 1780 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2013 | 139 | 0.090 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 198 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2018 | 3054 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 298 | 0.090 |
Why?
|
| Mutation | 1 | 2022 | 4272 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 373 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 245 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2014 | 372 | 0.080 |
Why?
|
| Calcium | 1 | 2013 | 1176 | 0.070 |
Why?
|
| Risk Factors | 1 | 2018 | 5899 | 0.070 |
Why?
|
| Lymph Node Excision | 1 | 2024 | 233 | 0.050 |
Why?
|
| Postmenopause | 1 | 2022 | 106 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2024 | 283 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 440 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 762 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1518 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 573 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 154 | 0.030 |
Why?
|
| Food | 1 | 2018 | 92 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 125 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2025 | 1691 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2018 | 337 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1161 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 119 | 0.020 |
Why?
|
| Calmodulin | 1 | 2013 | 50 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2013 | 192 | 0.020 |
Why?
|
| Protons | 1 | 2013 | 102 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 422 | 0.020 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 81 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 493 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 121 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 1768 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 3502 | 0.010 |
Why?
|
| Male | 1 | 2018 | 44557 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 28155 | 0.010 |
Why?
|